Year |
Citation |
Score |
2009 |
Berg M, Bal G, Goeminne A, Van der Veken P, Versées W, Steyaert J, Haemers A, Augustyns K. Synthesis of bicyclic N-arylmethyl-substituted iminoribitol derivatives as selective nucleoside hydrolase inhibitors. Chemmedchem. 4: 249-60. PMID 19115304 DOI: 10.1002/Cmdc.200800231 |
0.629 |
|
2008 |
Goeminne A, Berg M, McNaughton M, Bal G, Surpateanu G, Van der Veken P, De Prol S, Versées W, Steyaert J, Haemers A, Augustyns K. N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase. Bioorganic & Medicinal Chemistry. 16: 6752-63. PMID 18571422 DOI: 10.1016/J.Bmc.2008.05.056 |
0.617 |
|
2008 |
Goeminne A, McNaughton M, Bal G, Surpateanu G, Van Der Veken P, De Prol S, Versées W, Steyaert J, Haemers A, Augustyns K. Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors. European Journal of Medicinal Chemistry. 43: 315-26. PMID 17582660 DOI: 10.1016/J.Ejmech.2007.03.027 |
0.614 |
|
2007 |
Goeminne A, McNaughton M, Bal G, Surpateanu G, Van der Veken P, De Prol S, Versées W, Steyaert J, Apers S, Haemers A, Augustyns K. 1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 2523-6. PMID 17317181 DOI: 10.1016/J.Bmcl.2007.02.017 |
0.616 |
|
2004 |
Pil J, Van der Veken P, Bal G, Augustyns K, Haemers A, Tytgat J. Synthesis and electrophysiological characterization of cyclic morphiceptin analogues. Biochemical Pharmacology. 67: 1887-95. PMID 15130765 DOI: 10.1016/J.Bcp.2004.02.011 |
0.51 |
|
2003 |
Bal G, Van der Veken P, Antonov D, Lambeir AM, Grellier P, Croft SL, Augustyns K, Haemers A. Prolylisoxazoles: potent inhibitors of prolyloligopeptidase with antitrypanosomal activity. Bioorganic & Medicinal Chemistry Letters. 13: 2875-8. PMID 14611847 DOI: 10.1016/S0960-894X(03)00579-1 |
0.592 |
|
2002 |
Senten K, Van der Veken P, Bal G, De Meester I, Lambeir AM, Scharpé S, Bauvois B, Haemers A, Augustyns K. Development of potent and selective dipeptidyl peptidase II inhibitors. Bioorganic & Medicinal Chemistry Letters. 12: 2825-8. PMID 12270155 DOI: 10.1016/S0960-894X(02)00603-0 |
0.564 |
|
2002 |
Amssoms K, Oza SL, Augustyns K, Yamani A, Lambeir AM, Bal G, Van der Veken P, Fairlamb AH, Haemers A. Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 2: substitution of the glycine part. Bioorganic & Medicinal Chemistry Letters. 12: 2703-5. PMID 12217358 DOI: 10.1016/S0960-894X(02)00538-3 |
0.708 |
|
2002 |
Amssoms K, Oza SL, Ravaschino E, Yamani A, Lambeir A, Rajan P, Bal G, Rodriguez J, Fairlamb AH, Augustyns K, Haemers A. Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 1: Substitution of the glycine carboxylic acid group. Bioorganic & Medicinal Chemistry Letters. 12: 2553-6. PMID 12182858 DOI: 10.1016/S0960-894X(02)00489-4 |
0.685 |
|
2001 |
Lambeir AM, Proost P, Durinx C, Bal G, Senten K, Augustyns K, Scharpé S, Van Damme J, De Meester I. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. The Journal of Biological Chemistry. 276: 29839-45. PMID 11390394 DOI: 10.1074/Jbc.M103106200 |
0.494 |
|
2001 |
Senten K, Van Der Veken P, Bal G, Haemers A, Augustyns K. Polymer-assisted solution-phase parallel synthesis of dipeptide p-nitroanilides and dipeptide diphenyl phosphonates Tetrahedron Letters. 42: 9135-9138. DOI: 10.1016/S0040-4039(01)01954-2 |
0.52 |
|
2000 |
De Meester I, Durinx C, Bal G, Proost P, Struyf S, Goossens F, Augustyns K, Scharpé S. Natural substrates of dipeptidyl peptidase IV. Advances in Experimental Medicine and Biology. 477: 67-87. PMID 10849732 DOI: 10.1007/0-306-46826-3_7 |
0.534 |
|
1999 |
Augustyns K, Bal G, Thonus G, Belyaev A, Zhang XM, Bollaert W, Lambeir AM, Durinx C, Goossens F, Haemers A. The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors. Current Medicinal Chemistry. 6: 311-27. PMID 10101215 |
0.533 |
|
1999 |
Proost P, Struyf S, Schols D, Opdenakker G, Sozzani S, Allavena P, Mantovani A, Augustyns K, Bal G, Haemers A, Lambeir AM, Scharpé S, Van Damme J, De Meester I. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. The Journal of Biological Chemistry. 274: 3988-93. PMID 9933589 DOI: 10.1074/Jbc.274.7.3988 |
0.478 |
|
Show low-probability matches. |